Physician profile
Rohit Malhotra
NPI 1659372225
$701.45
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $348 · 2021: $19.98 · 2023: $17.94 · 2024: $74.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $61.57 · Food and Beverage: $31.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $61.57 |
| Food and Beverage | $31.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $177.33 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $124.95 | 2019-2020 | |
| Abiomed | $114.69 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $108.46 | 2019-2020 | |
| Medtronic, INC. | $61.57 | 2024 | Evera Mri Xt Dr Surescan |
| Shockwave Medical, INC | $22.35 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.90 | 2020 | |
| Avinger INC. | $19.98 | 2021 | |
| Abbott Laboratories | $19.11 | 2019 | |
| Glaxosmithkline, LLC. | $17.94 | 2023 | Arexvy, Shingrix |
| Amgen INC. | $13.17 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.